In the USA, it is estimated that around 40% of cases of end-stage renal disease attributed to FSGS occur in black individuals, and that approximately 72% of these cases are associated with the presence of risk variants in the APOL1 gene [8]. Here, APOL1 is linked to focal segmental glomerulosclerosis.